Cobalamin acquisition protein and use thereof

US9758550B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9758550-B2
Application numberUS-201514958321-A
CountryUS
Kind codeB2
Filing dateDec 3, 2015
Priority dateApr 30, 2012
Publication dateSep 12, 2017
Grant dateSep 12, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a cobalamin acquisition protein, compositions containing the cobalamin acquisition protein, and the use of such compositions.

First claim

Opening claim text (preview).

What is claimed is: 1. A pharmaceutical composition comprising a protein that binds Vitamin B 12 , said protein comprising an amino acid sequence having at least 90% identity with SEQ ID NO: 2, and a pharmaceutically acceptable excipient. 2. The composition of claim 1 , wherein the protein binds Vitamin B 12 with an affinity less than 10 −5 M. 3. The composition of claim 1 , wherein the composition is a liquid, solid, cream, or paste. 4. The composition of claim 1 , wherein the protein binds Vitamin B 12 with an affinity from about 10 −5 M to about 10 −12 M. 5. The composition of claim 1 , wherein the composition, when administered to a subject, is capable of reducing the growth and/or proliferation of a microorganism in or on the subject. 6. The composition of claim 1 , wherein the protein comprises from about 0.1% (w/w) to about 90% (w/w) of the pharmaceutical composition. 7. The composition of claim 6 , wherein the protein comprises from about 0.5% (w/w) to about 30% (w/w) of the pharmaceutical composition. 8. A method of treating a bacterial infection in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of the composition of claim 1 . 9. The method of claim 8 , wherein the composition is administered topically or orally to the subject. 10. The method of claim 8 , wherein the composition is administered non-parenterally to the subject.

Assignees

Inventors

Classifications

  • G01N33/82Primary

    involving vitamins {or their receptors} · CPC title

  • Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00) · CPC title

  • from invertebrates · CPC title

  • C07K14/00Primary

    Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof · CPC title

  • from algae · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9758550B2 cover?
The present invention relates to a cobalamin acquisition protein, compositions containing the cobalamin acquisition protein, and the use of such compositions.
Who is the assignee on this patent?
Woods Hole Oceanographic Inst
What technology area does this patent fall under?
Primary CPC classification G01N33/82. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).